Next 10 |
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...
Curis, Inc. (NASDAQ: CRIS) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 26.77% on the day to $16.99. Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment ...
2024-02-09 10:15:03 ET Piper Sandler analyst issues BUY recommendation for CRIS on February 9, 2024 08:11AM ET. The previous analyst recommendation was Buy. CRIS was trading at $10.65 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curren...
2024-02-08 16:39:01 ET More on Curis Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Curi s Read the full article on Seeking Alpha For further details see: Curis files for $300M common stock offering
2024-02-08 14:04:08 ET Curis, Inc. (CRIS) Q4 2023 Earnings Conference Call February 8, 2024 08:30 AM ET Company Participants Diantha Duvall - Chief Financial Officer Jim Dentzer - President & Chief Executive Officer Jonathan Zung - Chief Development Officer ...
2024-02-08 08:02:57 ET More on Curis Seeking Alpha’s Quant Rating on Curis Historical earnings data for Curis Financial information for Curis Read the full article on Seeking Alpha For further details see: Curis GAAP EPS of -$2.03 beats by ...
Curis Provides Fourth Quarter 2023 Business Update PR Newswire Emavusertib data presented at ASH showed 3 of 5 patients achieved CR in R/R PCNSL Expansion of clinical sites in US and Europe in progress Cash runway into 2025 Management to host confer...
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
2024-02-07 11:17:34 ET More on Curis Seeking Alpha’s Quant Rating on Curis Historical earnings data for Curis Financial information for Curis Read the full article on Seeking Alpha For further details see: Curis Q4 2023 Earnings Preview
Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024 PR Newswire LEXINGTON, Mass. , Feb. 1, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948)...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 62.9% to $0.0373 on volume of 466,310,671 shares INVO BioScience Inc. (INVO) rose 139.5% to $1.82 on volume of 225,666,770 shares PROSHARES TRUST (SQQQ) rose 3.7% to $11.86 on volume of 167,545,988 ...
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in ...
Curis, Inc. (NASDAQ: CRIS) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 26.77% on the day to $16.99. Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment ...